Chronic Effect of Combined Treatment With Omapatrilat and Adrenomedullin on the Progression of Heart Failure in Rats

Our results suggest that combined treatment with adrenomedullin and omapatrilat may be a new strategy for the management of heart failure, acting partly by inhibition of the extracellular matrix gene, adhesion molecule, antifibrinolysis, and oxidative stress production.